ACLX
Price
$79.11
Change
-$0.64 (-0.80%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
4.42B
49 days until earnings call
KRYS
Price
$176.88
Change
+$9.06 (+5.40%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
4.86B
42 days until earnings call
Interact to see
Advertisement

ACLX vs KRYS

Header iconACLX vs KRYS Comparison
Open Charts ACLX vs KRYSBanner chart's image
Arcellx
Price$79.11
Change-$0.64 (-0.80%)
Volume$7.65K
Capitalization4.42B
Krystal Biotech
Price$176.88
Change+$9.06 (+5.40%)
Volume$6.72K
Capitalization4.86B
ACLX vs KRYS Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. KRYS commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and KRYS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ACLX: $79.75 vs. KRYS: $167.82)
Brand notoriety: ACLX and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 94% vs. KRYS: 56%
Market capitalization -- ACLX: $4.42B vs. KRYS: $4.86B
ACLX [@Biotechnology] is valued at $4.42B. KRYS’s [@Biotechnology] market capitalization is $4.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 6 TA indicator(s) are bullish while KRYS’s TA Score has 7 bullish TA indicator(s).

  • ACLX’s TA Score: 6 bullish, 4 bearish.
  • KRYS’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а +2.43% price change this week, while KRYS (@Biotechnology) price change was +2.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.29%. For the same industry, the average monthly price growth was +11.39%, and the average quarterly price growth was +59.66%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

KRYS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.86B) has a higher market cap than ACLX($4.42B). KRYS YTD gains are higher at: 7.124 vs. ACLX (3.990). KRYS has higher annual earnings (EBITDA): 158M vs. ACLX (-179.78M). KRYS has more cash in the bank: 682M vs. ACLX (453M). KRYS has less debt than ACLX: KRYS (9.68M) vs ACLX (52.5M). KRYS has higher revenues than ACLX: KRYS (359M) vs ACLX (57M).
ACLXKRYSACLX / KRYS
Capitalization4.42B4.86B91%
EBITDA-179.78M158M-114%
Gain YTD3.9907.12456%
P/E RatioN/A34.11-
Revenue57M359M16%
Total Cash453M682M66%
Total Debt52.5M9.68M542%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
35
SMR RATING
1..100
53
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXKRYS
RSI
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGVNX29.970.31
+1.05%
TCW Relative Value Mid Cap N
DVLCX23.660.22
+0.94%
BNY Mellon Opportunistic Midcap Value C
ICSCX29.450.20
+0.68%
William Blair Small Cap Value I
FBALX32.590.11
+0.34%
Fidelity Balanced
FELIX117.390.10
+0.09%
Fidelity Advisor Semiconductors I

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+1.72%
CGON - ACLX
56%
Loosely correlated
+2.91%
XNCR - ACLX
53%
Loosely correlated
+12.00%
ROIV - ACLX
53%
Loosely correlated
+1.40%
BEAM - ACLX
52%
Loosely correlated
-0.52%
RNA - ACLX
52%
Loosely correlated
+5.17%
More